cystamine has been researched along with Inflammation in 11 studies
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our study provided some clues that tTG inhibitors NTU283 and Cystamine might be potential candidates for the treatments of neuroinflammation-related diseases, although more studies needed for further exploration." | 3.85 | Inhibition of tissue transglutaminase attenuates lipopolysaccharide-induced inflammation in glial cells through AKT/mTOR signal pathway. ( Ding, Y; Wang, R; Zhang, J, 2017) |
| " This protection is correlated with reduced apoptosis and inflammation and is reversed by treating mutant animals with cystamine." | 3.72 | Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress. ( Berruyer, C; Castellano, R; Duprè, S; Galland, F; Garrido-Urbani, S; Imbert, J; Macone, A; Malergue, F; Martin, FM; Millet, V; Naquet, P; Pitari, G, 2004) |
| "Inflammation is the primary problem associated with blood-contacting artificial organs." | 1.39 | QCM biosensor for testing the inflammatory response to blood-contacting biomaterials. ( Haberal, E; Kocakulak, M; Ugur, N, 2013) |
| "Cystamine pre-treatment restored ΔF508-CFTR response to the CFTR potentiators genistein, Vrx-532 or Vrx-770 in freshly isolated brushed nasal epithelial cells from ΔF508-CFTR homozygous patients." | 1.38 | Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator. ( Carnuccio, R; De Matteis, A; Esposito, S; Gavina, M; Guido, S; Kroemer, G; Luciani, A; Luini, A; Maiuri, L; Maiuri, MC; Pettoello-Mantovani, M; Raia, V; Russo, I; Scholte, B; Silano, M; Villella, VR, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L | 1 |
| Liu, S | 1 |
| Xiao, L | 1 |
| Chen, K | 1 |
| Tang, J | 1 |
| Huang, C | 1 |
| Luo, W | 1 |
| Ferrandon, D | 1 |
| Lai, K | 1 |
| Li, Z | 1 |
| Ding, Y | 1 |
| Zhang, J | 1 |
| Wang, R | 1 |
| Luciani, A | 2 |
| Villella, VR | 2 |
| Esposito, S | 2 |
| Brunetti-Pierri, N | 1 |
| Medina, D | 1 |
| Settembre, C | 1 |
| Gavina, M | 2 |
| Pulze, L | 1 |
| Giardino, I | 1 |
| Pettoello-Mantovani, M | 2 |
| D'Apolito, M | 1 |
| Guido, S | 2 |
| Masliah, E | 1 |
| Spencer, B | 1 |
| Quaratino, S | 1 |
| Raia, V | 2 |
| Ballabio, A | 1 |
| Maiuri, L | 2 |
| Park, KS | 1 |
| Kim, DS | 1 |
| Ko, C | 1 |
| Lee, SJ | 1 |
| Oh, SH | 1 |
| Kim, SY | 1 |
| Russo, I | 1 |
| Silano, M | 1 |
| Carnuccio, R | 1 |
| Scholte, B | 1 |
| De Matteis, A | 1 |
| Maiuri, MC | 1 |
| Luini, A | 1 |
| Kroemer, G | 1 |
| Haberal, E | 1 |
| Ugur, N | 1 |
| Kocakulak, M | 1 |
| CESSION-FOSSION, A | 1 |
| LECOMTE, J | 1 |
| FRANCHIMONT, P | 1 |
| Berruyer, C | 1 |
| Martin, FM | 1 |
| Castellano, R | 1 |
| Macone, A | 1 |
| Malergue, F | 1 |
| Garrido-Urbani, S | 1 |
| Millet, V | 1 |
| Imbert, J | 1 |
| Duprè, S | 1 |
| Pitari, G | 1 |
| Naquet, P | 1 |
| Galland, F | 1 |
| Hsu, TC | 1 |
| Huang, CY | 1 |
| Chiang, SY | 1 |
| Lai, WX | 1 |
| Tsai, CH | 1 |
| Tzang, BS | 1 |
| Leu, RW | 1 |
| Herriott, MJ | 1 |
| Moore, PE | 1 |
| Orr, GR | 1 |
| Birckbichler, PJ | 1 |
| Nakagawa, H | 1 |
| Watanabe, K | 1 |
| Shuto, K | 1 |
| Tsurufuji, S | 1 |
11 other studies available for cystamine and Inflammation
| Article | Year |
|---|---|
An initial assessment of the involvement of transglutaminase2 in eosinophilic bronchitis using a disease model developed in C57BL/6 mice.
Topics: Animals; Asthma; Bronchitis; Cystamine; Cytokines; Disease Models, Animal; Eosinophils; Gene Express | 2021 |
Inhibition of tissue transglutaminase attenuates lipopolysaccharide-induced inflammation in glial cells through AKT/mTOR signal pathway.
Topics: Animals; Cell Line; Cyclooxygenase 2; Cystamine; Imidazoles; Inflammation; Lipopolysaccharides; Mice | 2017 |
Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.
Topics: Acetylcysteine; Adaptor Proteins, Signal Transducing; Adolescent; Adult; Animals; Antioxidants; Apop | 2010 |
TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2.
Topics: Adenoviridae; Animals; Blotting, Western; Cell Line; Cystamine; Electrophoretic Mobility Shift Assay | 2011 |
Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Animals; Antioxidants; Apoptosis Regulatory Protei | 2012 |
QCM biosensor for testing the inflammatory response to blood-contacting biomaterials.
Topics: Antibodies; Biocompatible Materials; Biosensing Techniques; Cells, Cultured; Complement C3a; Cystami | 2013 |
[Mechanism of the anti-inflammatory action of cystamine].
Topics: Anti-Inflammatory Agents; Blood Pressure; Blood Pressure Determination; Cystamine; Epinephrine; Infl | 1962 |
Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress.
Topics: Amidohydrolases; Animals; Apoptosis; Cell Adhesion Molecules; Cell Line; Cystamine; Cysteamine; Epit | 2004 |
Transglutaminase inhibitor cystamine alleviates the abnormality in liver from NZB/W F1 mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cystamine; Disease Models, Animal; Enzym | 2008 |
Enhanced transglutaminase activity associated with macrophage activation. Possible role in Fc-mediated phagocytosis.
Topics: Acyltransferases; Animals; Ascitic Fluid; Cadaverine; Cystamine; Dogs; Inflammation; Macrophage Acti | 1982 |
Anti-inflammatory effect of proteinase inhibitors on carrageenin-induced inflammation in rats.
Topics: Animals; Carrageenan; Cell Movement; Cystamine; Inflammation; Leupeptins; Male; Neutrophils; Phenant | 1983 |